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Abstract
The recent boom in microfluidics and combinatorial indexing strategies, combined with low sequencing costs, has
empowered single-cell sequencing technology. Thousands—or even millions—of cells analyzed in a single
experiment amount to a data revolution in single-cell biology and pose unique data science problems. Here, we
outline eleven challenges that will be central to bringing this emerging field of single-cell data science forward. For
each challenge, we highlight motivating research questions, review prior work, and formulate open problems. This
compendium is for established researchers, newcomers, and students alike, highlighting interesting and rewarding
problems for the coming years.
Introduction
Since being highlighted as “Method of the Year” in 2013
[1], sequencing of the genetic material of individual cells
has become routine when investigating cell-to-cell hetero-
geneity. Single-cell measurements of both RNA and DNA,
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and more recently also of epigenetic marks and protein
levels, can stratify cells at the finest resolution possible.
Single-cell RNA sequencing (scRNA-seq) enables
transcriptome-wide gene expression measurement at
single-cell resolution, allowing for cell type clusters to
be distinguished (for an early example, see [2]), the
arrangement of populations of cells according to novel
hierarchies, and the identification of cells transitioning
between states. This can lead to a much clearer view of
the dynamics of tissue and organism development, and
on structures within cell populations that had so far been
perceived as homogeneous. In a similar vein, analyses
based on single-cell DNA sequencing (scDNA-seq) can
highlight somatic clonal structures (e.g., in cancer, see [3,
4]), thus helping to track the formation of cell lineages
and provide insight into evolutionary processes acting on
somatic mutations.
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The opportunities arising from single-cell sequenc-
ing (sc-seq) are enormous: only now is it possible to
re-evaluate hypotheses about differences between pre-
defined sample groups at the single-cell level—no matter
if such sample groups are disease subtypes, treatment
groups, or simply morphologically distinct cell types. It is
therefore no surprise that enthusiasm about the possibility
to screen the genetic material of the basic units of life has
continued to grow. A prominent example is the Human
Cell Atlas [5], an initiative aiming to map the numerous
cell types and states comprising a human being.
Encouraged by the great potential of investigating DNA
and RNA at the single-cell level, the development of
the corresponding experimental technologies has experi-
enced considerable growth. In particular, the emergence
of microfluidics techniques and combinatorial indexing
strategies [6–10] has led to hundreds of thousands of cells
routinely being sequenced in one experiment. This devel-
opment has even enabled a recent publication analyzing
millions of cells at once [11]. Sc-seq datasets comprising
very large cell numbers are becoming available worldwide,
constituting a data revolution for the field of single-cell
analysis.
These vast quantities of data and the research hypothe-
ses that motivate them need to be handled in a compu-
tationally efficient and statistically sound manner [12]. As
these aspects clearly match a recent definition of “Data
Science” [13], we posit that we have entered the era of
single-cell data science (SCDS).
SCDS exacerbates many of the data science issues aris-
ing in bulk sequencing, but it also constitutes a set of
new, unique challenges for the SCDS community to tackle.
Limited amounts of material available per cell lead to high
levels of uncertainty about observations. When amplifica-
tion is used to generate more material, technical noise is
added to the resulting data. Further, any increase in res-
olution results in another—rapidly growing—dimension
in data matrices, calling for scalable data analysis models
and methods. Finally, no matter how varied the chal-
lenges are—by research goal, tissue analyzed, experimen-
tal setup, or just by whether DNA or RNA is sequenced—
they are all rooted in data science, i.e., are computational
or statistical in nature. Here, we propose the data science
challenges that we believe to be among the most relevant
for bringing SCDS forward.
This catalog of SCDS challenges aims at focusing the
development of data analysis methods and the directions
of research in this rapidly evolving field. It shall serve as
a compendium for researchers of various communities,
looking for rewarding problems that match their personal
expertise and interests. To make it accessible to these
different communities, we categorize challenges into the
following: transcriptomics (see “Challenges in single-cell
transcriptomics”), genomics (see the “Challenges in sin-
gle-cell genomics”), and phylogenomics (see “Challenges
in single-cell phylogenomics”). For each challenge, we pro-
vide a thorough review of the status relative to existing
approaches and point to possible directions of research to
solve it.
Several themes and aspects recur across the boundaries
of research communities and methodological approaches.
We represent these overlaps in three different ways. First,
we decided to discuss some problems in multiple con-
texts, highlighting the relevant aspects for the respective
research communities (e.g., data sparsity in transcrip-
tomics and genomics). Second, we separately introduce
recurring themes (see “Single-cell data science: recur-
ring themes”), thereby keeping respective discussions in
each challenge succinct. Third, if challenges were iden-
tified as independent of the chosen categorization, they
are discussed as recapitulatory challenges at the end (see
“Overarching challenges”).
Single-cell data science: recurring themes
A number of challenging themes are common to many or
all single-cell analyses, regardless of the particular assay
or data modality generated. We will start our review
by introducing them. Later, when discussing the specific
challenges, we will refer to these broader themes wherever
appropriate and outline what they mean in the particular
context. If challenges covered in later sections are partic-
ularly entangled with the broader themes listed here, we
will also refer to them from within this section.
The themes may reflect issues one also experiences
when analyzing bulk sequencing data. However, even
if not unique to single-cell experiments, these issues
may dominate the analysis of sc-seq data and there-
fore require particular attention. The two most urgent
elementary themes, not necessarily unique to sc-seq,
are the need to quantify measurement uncertainty (see
“Quantifying uncertainty of measurements and analy-
sis results”) and the need to benchmark methods sys-
tematically, in a way that highlights the metrics that
are particularly critical in sc-seq. Since the latter is of
central importance and an aspect that has gained vis-
ibility only recently, we not only mention its impor-
tance in relevant challenges, but also consider it a
challenge in its own right (see “Challenge XI: Vali-
dating and benchmarking analysis tools for single-cell
measurements”).
We identify three sweeping themes that are more spe-
cific to sc-seq, exacerbated by the rapid advances in
experimental technologies. First, there is a need to scale
to higher dimensional data, be it more cells measured
or more data measured per cell (see “Scaling to higher
dimensionalities: more cells, more features, and broader
coverage”). This need often arises in combination with
a second one: the need to integrate data across different
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Fig. 1 Different levels of resolution are of interest, depending on the research question and the data available. Thus, analysis tools and reference
systems (such as cell atlases) will have to accommodate multiple levels of resolution from whole organs and tissues over discrete cell types to
continuously mappable intermediate cell states, which are indistinguishable even at the microscopic level. A graph abstraction that enables such
multiple levels of focus is provided by PAGA [14], a structure that allows for discretely grouping cells, as well as inferring trajectories as paths
through a graph
types of single-cell measurements (e.g., RNA, DNA, pro-
teins, and methylation) and across samples, be it from dif-
ferent time points, treatment groups, or even organisms.
This integration theme runs throughout multiple chal-
lenges and is so central that we consider it a challenge
worth highlighting (see “Challenge X: Integration of sin-
gle-cell data across samples, experiments, and types of
measurement”). Third, the possibility to operate on the
finest levels of resolution casts an important, overarching
question: what level of resolution is appropriate relative
to the particular research question one has in mind (see
“Varying levels of resolution”)? We will start by qualifying
this last one.
Varying levels of resolution
Sc-seq allows for a fine-grained definition of cell types and
states. Hence, it allows for characterizations of cell popu-
lations that are significantly more detailed than those sup-
ported by bulk sequencing experiments. However, even
though sc-seq operates at the most basic level, mapping
cell types and states at a particular level of resolution of
interest may be challenging: Achieving the targeted level
of resolution or granularity for the intended map of cells
may require substantial methodological efforts and will
depend on whether the research question allows for a
certain freedom in terms of resolution and on the limits
imposed by the particular experimental setup.
When drawing maps of cell types and states, it is impor-
tant that they (i) have a structure that recapitulates both
tissue development and tissue organization; (ii) account
for continuous cell states in addition to discrete cell types
(i.e., reflecting cell state trajectories within cell types and
smooth transitions between cell types, as observed in
tissue generation); (iii) allow for choosing the level of
resolution flexibly (i.e., the map should possibly support
zoom-type operations, to let the researcher choose the
desired level of granularity with respect to cell types
and states conveniently, ranging from whole organisms
via tissues to cell populations and cellular subtypes); and
(iv) include biological and functional annotation wherever
available and helpful in the intended functional context.
An exemplary illustration of how maps of cell types
and states can support different levels of resolution is the
structure-rich topologies generated by PAGA based on
scRNA-seq [14], see Fig. 11. At the highest levels of resolu-
tion, these topologies also reflect intermediate cell states
and the developmental trajectories passing through them.
A similar approach that also allows for consistently zoom-
ing into more detailed levels of resolution is provided by
hierarchical stochastic neighbor embedding (HSNE, Pez-
zotti et al. [15]), a method pioneered on mass cytometry
datasets [16, 17]. In addition, manifold learning [18, 19]
and metric learning [20, 21] may provide further the-
oretical support for even more accurate maps, because
they provide sound theories about reasonable, continuous
distance metrics, instead of just distinct, discrete clusters.
Quantifying uncertainty of measurements and analysis
results
The amount of material sampled from single cells is con-
siderably less than that used in bulk experiments. Signals
become more stable when individual signals are summa-
rized (such as in a bulk experiment); thus, the increase
in resolution due to sc-seq also means a reduction of
the stability of the supporting signals. The reduction in
signal stability, in turn, implies that data becomes sub-
stantially more uncertain and tasks so far considered
routine, such as single nucleotide variation (SNV) calling
in bulk sequencing, require considerable methodological
care with sc-seq data.
1Figure 1 was adapted from [14], Fig. 3, provided under Creative Commons
Attribution 4.0 International License (http://creativecommons.org/licenses/
by/4.0/).
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These issues with data quality and in particular miss-
ing data pose challenges that are unique to sc-seq, and are
thus at the core of several challenges: regarding scDNA-
seq data quality (see “Challenges in single-cell genomics”)
and especially regarding missing data in scDNA-seq
(“Challenge VI: Dealing with errors and missing data
in the identification of variation from single-cell DNA
sequencing data”) and scRNA-seq (“Challenge I: Handling
sparsity in single-cell RNA sequencing”). In contrast, the
non-negligible batch effects that scRNA-seq can suffer
from reflect a common problem in high-throughput data
analysis [22], and thus are not discussed here (although
in certain protocols such effects can be alleviated by care-
ful use of negative control data in the form of spike-in
RNA of known content and concentration, see, for exam-
ple, BEARscc [23]).
Optimally, sc-seq analysis tools would accurately quan-
tify all uncertainties arising from experimental errors and
biases. Such tools would prevent the uncertainties from
propagating to the intended downstream analyses in an
uncontrolled manner, and rather translate them into sta-
tistically sound and accurately quantified qualifiers of final
results.
Scaling to higher dimensionalities: more cells, more
features, and broader coverage
The current blossoming of experimental methods poses
considerable statistical challenges, and would do so even
if measurements were not affected by errors and biases.
The increase in the number of single cells analyzed per
experiment translates into more data points being gener-
ated, requiring methods to scale rapidly. Some scRNA-seq
SCDS methodology has started to address scalability [12,
24–27], but the respective issues have not been fully
resolved and experimental methodology will scale fur-
ther. For scDNA-seq, experimental methodology has just
been scaling up to more cells recently (see Table 1 and
“Challenge VII: Scaling phylogenetic models to many cells
and many sites”), making this a pressing challenge in the
development of data analysis methods.
Beyond basic scRNA-seq and scDNA-seq experiments,
various assays have been proposed to measure chromatin
accessibility [37, 38], DNA methylation [39], protein lev-
els [40], protein binding, and also for performing multiple
simultaneous measurements [41, 42] in single cells. The
corresponding increase in experimental choices means
another possible inflation of feature spaces.
In parallel to the increase in the number of cells queried
and the number of different assays possible, the increase
of the resolution per cell of specific measurement types
causes a steady increase of the dimensionality of corre-
sponding data spaces. For the field of SCDS, this amounts
to a severe and recurring case of the “curse of dimen-
sionality” for all types of measurements. Here again,
scRNA-seq-based methods are in the lead when trying to
deal with feature dimensionality, while scDNA-seq-based
methodology (which includes epigenome assays) has yet
to catch up.
Finally, there are efforts to measure multiple feature
types in parallel, e.g., from scDNA-seq (see “Challenge
VIII: Integrating multiple types of variation into phyloge-
netic models”). Also, with spatial and temporal sampling
becoming available (see “Challenge V: Finding patterns
in spatially resolved measurements” and “Challenge IX:
Inferring population genetic parameters of tumor hetero-
geneity by model integration”), data integration methods
need to scale to more and new types of context infor-
mation for individual cells (see “Challenge X: Integration
of single-cell data across samples, experiments, and types
of measurement” for a comprehensive discussion of data
integration approaches).
Challenges in single-cell transcriptomics
Challenge I: Handling sparsity in single-cell RNA
sequencing
A comprehensive characterization of the transcriptional
status of individual cells enables us to gain full insight into
the interplay of transcripts within single cells. However,
scRNA-seq measurements typically suffer from large frac-
tions of observed zeros, where a given gene in a given cell
Table 1 Whole genome amplification: recent improvements
Recent improvements of whole genome amplification (WGA) methods promise to reduce amplification biases and errors, while scaling throughput to
larger cell numbers:
1. Improved coverage uniformity for multiple displacement amplification (MDA) has been achieved using droplet microfluidics-based methods (eWGA
[28]; sd-MDA [29]; ddMDA [30]). A second approach has been to couple the 29 DNA polymerase to a primase to reduce priming bias [31].
2. One way to reduce the amplification error rate of the polymerase chain reaction (PCR)-based methods (including multiple annealing and
looping-based amplification cycles (MALBAC)) would be to employ a thermostable polymerase (necessary for use in PCR) with proof-reading activity
similar to 29 DNA polymerase, but we are not aware of any PCR DNA polymerases with a fidelity in the range of 29 DNA polymerase [32].
3. Three newer methods use an entirely different approach: they randomly insert transposons into the whole genome and then leverage these as
priming sites for amplification and library preparation. Transposon Barcoded (TnBC) library preparation (with a PCR amplification, [33]) and direct
library preparation (DLP) (with a shallow library without any amplification, [34]) allow only for copy number variation (CNV) calling, but DLP scales up
to 80,000 single cells [35]. Linear—as opposed to exponential—Amplification via Transposon Insertion (LIANTI, [36]) also addresses amplification
errors: all copies are generated based on the original genomic DNA through in vitro transcription. With errors unique to individual barcoded copies,
the authors report a false positive rate that is even lower than for MDA [36].
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has no unique molecular identifiers or reads mapping to
it. The term “dropout” is often used to denote observed
zero values in scRNA-seq data. But this term usually con-
flates two distinct types of zero values: those attributable
to methodological noise, where a gene is expressed but
not detected by the sequencing technology, and those
attributable to biologically-true absence of expression.
Thus, we recommend against the term “dropout” as a
catch-all term for observed zeros. Beyond biological vari-
ation in the number of unexpressed genes, the proportion
of observed zeros, or degree of sparsity, is attributed to
technical limitations [43, 44]. Those can result in artificial
zeros that are either systematic (e.g., sequence-specific
mRNA degradation during cell lysis) or that occur by
chance (e.g., barely expressed transcripts that—at the
same expression level, due to sampling variation—will
sometimes be detected and sometimes not). Accordingly,
the degree of sparsity depends on the scRNA-seq platform
used, the sequencing depth, and the underlying expression
level of the gene.
Sparsity in scRNA-seq data can hinder downstream
analyses and is still challenging to model or handle appro-
priately, calling for further method development. Spar-
sity pervades all aspects of scRNA-seq data analysis, but
in this challenge, we focus on the linked problems of
learning latent spaces and “imputing” expression values
from scRNA-seq data (Fig. 2). Imputation approaches
are closely linked to the challenges of normalization. But
whereas normalization generally aims to make expression
values between cells and experiments more compara-
ble to each other, imputation approaches aim to achieve
adjusted data values that better represent the true expres-
sion values. Imputation methods could therefore be used
for normalization, but do not entail all possible or useful
approaches to normalization.
Status
The imputation of missing values has been very suc-
cessful for genotype data [45]. Crucially, when imputing
genotypes, we typically know which data are missing
(e.g., when no genotype call is possible due to no coverage
of a locus; although see the “Challenge VI: Dealing with
errors and missing data in the identification of variation
from single-cell DNA sequencing data” for the challenges
with scDNA-seq data). In addition, rich sources of exter-
nal information are available (e.g., haplotype reference
panels). Thus, genotype imputation is now highly accurate
and a commonly used step in data processing for genetic
association studies [46].
The situation is somewhat different for scRNA-seq data,
as we do not routinely have external reference informa-
tion to apply (see “Challenge III: Mapping single cells to a
reference atlas”). In addition, we can never be sure which
of the observed zeros represent “missing data” and which
accurately represent a true absence of gene expression in
the cell [43].
In general, two broad approaches can be applied to
tackle this problem of sparsity: (i) use statistical mod-
els that inherently model the sparsity, sampling variation,
and noise modes of scRNA-seq data with an appropri-
ate data generative model (i.e., quantifying uncertainty,
see the “Quantifying uncertainty of measurements and
analysis results”), or (ii) attempt to “impute” values for
observed zeros (ideally the technical zeros; sometimes
also non-zero values) that better approximate the true
gene expression levels (Fig. 2). We prefer to use the
first option where possible, and for many single-cell data
analysis problems, there already are statistical models
appropriate for sparse count data that should be used or
extended (e.g., for differential expression analysis, see the
“Challenge II: Defining flexible statistical frameworks for
discovering complex differential patterns in gene expres
sion”). However, there are many cases where the appro-
priate models are not available and accurate imputa-
tion of technical zeros would allow better results from
downstream methods and algorithms that cannot handle
sparse count data. For example, depending on the amount
of sparsity, imputation could potentially improve results
of dimension reduction, visualization, and clustering
applications.
Fig. 2 Measurement error requires denoising methods or approaches that quantify uncertainty and propagate it down analysis pipelines. Where
methods cannot deal with abundant missing values, imputation approaches may be useful. While the true population manifold that generated data
is never known, one can usually obtain some estimation of it that can be used for both denoising and imputation
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We define three broad (and often overlapping) cate-
gories ofmethods that can be used to “impute” scRNA-seq
data in the absence of an external reference (Table 2): (A)
Model-based imputation methods of technical zeros use
probabilistic models to identify which observed zeros rep-
resent technical rather than biological zeros. They aim to
impute expression levels only for the technical zeros, leav-
ing other observed expression levels untouched. (B)Data-
smoothing methods define a “similarity” between cells
(e.g., cells that are neighbors in a graph or occupy a small
region in a latent space) and adjust expression values for
each cell based on expression values in similar cells. These
methods usually adjust all expression values, including
technical zeros, biological zeros, and observed non-zero
values. (C) Data-reconstruction methods typically aim to
define a latent space representation of the cells. This is
often done through matrix factorization (e.g., principal
component analysis) or, increasingly, through machine
learning approaches (e.g., variational autoencoders that
exploit deep neural networks to capture non-linear
relationships). Both matrix factorization methods and
autoencoders (among others) are able to “reconstruct” the
observed data matrix from low-rank or simplified repre-
sentations. The reconstructed data matrix will typically
no longer be sparse (with many zeros), and the implic-
itly “imputed” data (or estimated latent spaces if using,
for example, variational autoencoders) can be used for
downstream applications such as clustering or trajectory
inference (see “Challenge IV: Generalizing trajectory infe-
rence”). A fourth—distinct—category is (T) imputation
with an external dataset or reference, using it for transfer
learning.
The first category of methods generally seeks to infer
a probabilistic model that captures the data generation
mechanism. Such generative models can be used to prob-
abilistically determine which observed zeros correspond
to technical zeros (to be imputed) and which corre-
spond to biological zeros (to be left alone). There are
many model-based imputation methods already available
that use ideas from clustering (e.g., k-means), dimension
reduction, regression, and other techniques to impute
technical zeros, oftentimes combining ideas from several
of these approaches (Table 2 (A)).
Data-smoothing methods adjust all gene expression
levels based on expression levels in “similar” cells,
aiming to “denoise” the values (Fig. 2). Several such
methods have been proposed to handle imputation
problems (Table 2 (B)). To take a simplified example
(Fig. 2), we might imagine that single cells originally
refer to points along a curve across a two-dimensional
space. Projecting data points onto that curve eventu-
ally allows imputation of the “missing” values (but all
points are adjusted, or smoothed, not just true technical
zeros).
A major task in the analysis of high-dimensional single-
cell data is to find low-dimensional representations of
the data that capture the salient biological signals and
render the data more interpretable and amenable to fur-
ther analyses. As it happens, the matrix factorization and
latent-space learning methods used for that task also pro-
vide a third route for imputation: they can reconstruct the
observed datamatrix from simplified representations of it.
Principal component analysis (PCA) is one standard
matrix factorization method that can be applied to
scRNA-seq data (preferably after suitable data normaliza-
tion) as are other widely used general statistical methods
like independent component analysis (ICA) and non-
negative matrix factorization (NMF). As (linear) matrix
factorization methods, PCA, ICA, and NMF decompose
the observed data matrix into a “small” number of fac-
tors in two low-rank matrices, one representing cell-by-
factor weights and one gene-by-factor loadings. Many
matrix factorization methods with tweaks for single-cell
data have been proposed in recent years (Table 2 (C)),
with some specifically intended for imputation (ALRA,
ENHANCE, scRMD).
Additionally, machine learning methods have been pro-
posed for scRNA-seq data analysis that can, but need
not, use probabilistic data generative processes to cap-
ture low-dimensional or latent space representations of a
dataset (Table 2 (C)). Some of them are expressly aimed
at imputation (e.g., AutoImpute, DeepImpute, EnImpute,
DCA, and scVI). But even if imputation is not the main
focus, such methods can generate “imputed” expression
values as an upshot of a model primarily focused on other
tasks, like learning latent spaces, clustering, batch cor-
rection, or visualization (and often several of these tasks
simultaneously).
Finally, a small number of scRNA-seq imputation
methods extend approaches from any (combination) of
the three categories above by incorporating information
external to the current dataset (Table 2 (T)). Approaches
using cell atlas-type reference resources are further dis-
cussed in the “Challenge III: Mapping single cells to a
reference atlas” section and classified as approach +X+S
in the “Challenge X: Integration of single-cell data across
samples, experiments, and types of measurement” (see
Fig. 6 and Table 4).
Open problems
A major challenge in this context is the circularity that
arises when imputation solely relies on information that is
internal to the imputed dataset. This circularity can arti-
ficially amplify the signal contained in the data, leading
to inflated correlations between genes or cells. In turn,
this can introduce false positives in downstream analy-
ses such as differential expression testing and gene net-
work inference [90]. Handling batch effects and potential
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Table 2 Short description of methods for the imputation of missing data in scRNA-seq data
A: model-based imputation
bayNorm Binomial model, empirical Bayes prior [47]
BISCUIT Gaussian model of log counts, cell- and cluster-specific parameters [48]
CIDR Decreasing logistic model (DO), non-linear least-squares regression (imp) [49]
SAVER NB model, Poisson LASSO regression prior [50]
ScImpute Mixture model (DO), non-negative least squares regression (imp) [51]
scRecover ZINB model (DO identification only) [52]
VIPER Sparse non-negative regression model [53]
B: data smoothing
DrImpute k-means clustering of PCs of correlation matrix [54]
knn-smooth k-nearest neighbor smoothing [55]
LSImpute Locality sensitive imputation [56]
MAGIC Diffusion across nearest neighbor graph [57]
netSmooth Diffusion across PPI network [58]
C: data reconstruction, matrix factorization
ALRA SVD with adaptive thresholding [59]
ENHANCE Denoising PCA with aggregation step [60]
scRMD Robust matrix decomposition [61]
consensus NMF Meta-analysis approach to NMF [62]
f-scLVM Sparse Bayesian latent variable model [63]
GPLVM Gaussian process latent variable model [64]
pCMF Probab. count matrix factorization with Poisson model [65]
scCoGAPS Extension of NMF [66]
SDA Sparse decomposition of arrays (Bayesian) [67]
ZIFA ZI factor analysis [68]
ZINB-WaVE ZINB factor model [69]
C: data reconstruction, machine learning
AutoImpute AE, no error back-propagation for zero counts [70]
BERMUDA AE for cluster batch correction (MMD and MSE loss function) [71]
DeepImpute AE, parallelized on gene subsets [72]
DCA Deep count AE (ZINB / NB model) [73]
DUSC / DAWN Denoising AE (PCA determines hidden layer size) [74]
EnImpute Ensemble learning consensus of other tools [75]
Expression Saliency AE (Poisson negative log-likelihood loss function) [76]
LATE Non-zero value AE (MSE loss function) [77]
Lin_DAE Denoising AE (imputation across k-nearest neighbor genes) [78]
SAUCIE AE (MMD loss function) [79]
scScope Iterative AE [80]
scVAE Gaussian-mixture VAE (NB / ZINB / ZIP model) [81]
scVI VAE (ZINB model) [82]
scvis VAE (objective function based on latent variable model and t-SNE) [83]
VASC VAE (denoising layer; ZI layer, double-exponential and Gumbel distribution) [84]
Zhang_VAE VAE (MMD loss function) [85]
T: using external information
ADImpute Gene regulatory network information [86]
netSmooth PPI network information [58]
SAVER-X Transfer learning with atlas-type resources [87]
SCRABBLE Matched bulk RNA-seq data [88]
TRANSLATE Transfer learning with atlas-type resources [77]
URSM Matched bulk RNA-seq data [89]
Imputation methods using only data from within a dataset are roughly categorized approaches A (model-based), B (data smoothing), and C (data reconstruction), with the
latter further differentiated into matrix factorization and machine learning approaches. In contrast to these methods, those in category T (for transfer learning) also use
information external to the dataset to be analyzed
AE autoencoder, DO dropout, imp imputation,MMDmaximummean discrepancy,MSE mean squared error, NB negative binomial, NMF non-negative matrix factorization, P
Poisson, PC principal component, PCA principal component analysis, PPI protein-protein interaction, SVD singular value decomposition, VAE variational autoencoder, ZI
zero-inflated
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confounders requires further work to ensure that impu-
tation methods do not mistake unwanted variation from
technical sources for biological signal. In a similar vein,
single-cell experiments are affected by various uncer-
tainties (see “Quantifying uncertainty of measurements
and analysis results”). Approaches that allow quantifi-
cation and propagation of the uncertainties associated
with expression measurements (see “Quantifying uncer-
tainty of measurements and analysis results”) may help to
avoid problems associated with “overimputation” and the
introduction of spurious signals noted by Andrews and
Hemberg [90].
To avoid this circularity, it is important to identify reli-
able external sources of information that can inform the
imputation process. One possibility is to exploit external
reference panels (like in the context of genetic associa-
tion studies). Such panels are not generally available for
scRNA-seq data, but ongoing efforts to develop large scale
cell atlases (e.g., [5]) could provide a valuable resource for
this purpose. Some methods have been extended to allow
the use of such resources (e.g., SAVER-X and TRANS-
LATE), but this will need to be done for all approaches (see
“Challenge III: Mapping single cells to a reference atlas”).
A second approach to avoid circularity is the system-
atic integration of known biological network structures in
the imputation process. This can be achieved by encod-
ing network structure knowledge as prior information, as
proposed by ADImpute and netSmooth and the tool by
Lin et al. [78].
Finally, a third way of avoiding circularity in imputation
is to explore complementary types of data that can inform
scRNA-seq imputation. This idea was adopted in SCRAB-
BLE and URSM, where an external reference is defined
by bulk expression measurements from the same popula-
tion of cells for which imputation is performed. Of course,
such orthogonal information can also be provided by dif-
ferent types of molecular measurements (see “Challenge
X: Integration of single-cell data across samples, experi-
ments, and types of measurement”). Methods designed
to integrate multi-omics data could then be extended to
enable scRNA-seq imputation, for example, through gen-
erative models that explicitly link scRNA-seq with other
data types (e.g., clonealign [91]) or by inferring a shared
low-dimensional latent structure (e.g., MOFA [92]) that
could be used within a data-reconstruction framework.
With the proliferation of alternative methods, compre-
hensive benchmarking is urgently required—as for all
areas of single-cell data analysis (see “Challenge XI: Vali-
dating and benchmarking analysis tools for single-cell
measurements”). Early attempts by Zhang and Zhang
[93] and Andrews and Hemberg [90] provide valuable
insights into the performance of methods available at the
time. But many more methods have since been proposed
and even more comprehensive benchmarking platforms
are needed. Some methods, especially those using deep
learning, depend strongly on choice of hyperparameters
[94]. There, more detailed comparisons that explore para-
meter spaces would be helpful, extending work like that
from Sun et al. [95] comparing dimensionality reduction
methods. Such detailed benchmarking would also help
to establish when normalization methods derived from
explicit count models (e.g., [96, 97]) may be preferable to
imputation.
Finally, scalability for large numbers of cells remains an
ongoing concern for methods allowing for imputation, as
for all high-throughput single-cell methods and software
(see “Scaling to higher dimensionalities: more cells, more
features, and broader coverage”).
Challenge II: Defining flexible statistical frameworks for
discovering complex differential patterns in gene
expression
Beyond simple changes in average gene expression
between cell types (or across bulk-collected libraries),
scRNA-seq enables a high granularity of changes in
expression to be unraveled. Interesting and informative
changes in expression patterns can be revealed, as well
as cell type-specific changes in cell state across sam-
ples (Fig. 6, approach +S). Further understanding of gene
expression changes will enable deeper knowledge across
a myriad of applications, such as immune responses [98,
99], development [100], and drug responses [101].
Status
Currently, the vast majority of differential expression
detection methods assume that the groups of cells to be
compared are known in advance (e.g., experimental con-
ditions or cell types). However, current analysis pipelines
typically rely on clustering or cell type assignment to
identify such groups, before downstream differential anal-
ysis is performed, without propagating the uncertainty in
these assignments or accounting for the double use of data
(clustering, differential testing between clusters).
In this context, most methods have focused on com-
paring average expression between groups [102, 103],
but it appears that single cell-specific methods do not
uniformly outperform the state-of-the-art bulk methods
[104]. Some attention has been given to more general pat-
terns of differential expression (Fig. 3), such as changes
in variability that account for mean expression con-
founding [105], changes in trajectory along pseudotime
[106, 107], or more generally, changes in distributions
[108]. Furthermore, methods for cross-sample compar-
isons of gene expression (e.g., cell type-specific changes
in cell state across samples; see the “Challenge X: Integra-
tion of single-cell data across samples, experiments, and
types of measurement”, Fig. 6 and Table 4) are now
emerging, such as pseudo-bulk analyses [109–111], where
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Fig. 3 Differential expression of a gene or transcript between cell
populations. The top row labels the specific gene or transcript, as is
also done in Fig. 6. A difference inmean gene expression manifests in
a consistent difference of gene expression across all cells of a
population (e.g., high vs. low). A difference in variability of gene
expression means that in one population, all cells have a very similar
expression level, whereas in another population, some cells have a
much higher expression and some a much lower expression. The
resulting average expression level may be the same, and in such
cases, only single-cell measurements can find the difference between
populations. A difference across pseudotime is a change of expression
within a population, for example, along a developmental trajectory
(compare Fig. 1). This also constitutes a difference between cell
populations that is not apparent from population averages, but
requires a pseudo-temporal ordering of measurements on single cells
expression is aggregated over multiple cells within each
sample, or mixed models, where both within- and
between-sample variation is captured [111, 112]. With the
expanding capacity of experimental techniques to gener-
ate multi-sample scRNA-seq datasets, further general and
flexible statistical frameworks will be required to identify
complex differential patterns across samples. This will be
particularly critical in clinical applications, where cells are
collected from multiple patients.
Open problems
Accounting for uncertainty in cell type assignment and
for double use of data will require, first of all, a system-
atic study of their impact. Integrative approaches in which
clustering and differential testing are simultaneously per-
formed [113] can address both issues. However, integra-
tive methods typically require bespoke implementations,
precluding a direct combination between arbitrary clus-
tering and differential testing tools. In such cases, the
adaptation of selective inferencemethods [114] could pro-
vide an alternative solution, with an approach based on
correcting the selection bias recently proposed [115].
While some methods exist to identify more general
patterns of gene expression changes (e.g., variability, dis-
tributions), these methods could be further improved by
integrating with existing approaches that account for con-
founding effects such as cell cycle [116] and complex
batch effects [117, 118]. Moreover, our capability to dis-
cover interesting gene expression patterns will be vastly
expanded by connecting with other aspects of single-
cell expression dynamics, such as cell type composition,
RNA velocity [119], splicing, and allele specificity. This
will allow us to fully exploit the granularity contained in
single-cell level expression measurements.
In the multi-donor setting, several promising meth-
ods have been applied to discover state transitions in
high-dimensional cytometry datasets [120–124]. These
approaches could be expanded to the higher dimen-
sions and characteristic aspects of scRNA-seq data. Alter-
natively, there is a large space to explore other gen-
eral and flexible approaches, such as hierarchical mod-
els where information is borrowed across samples or
exploring changes in full distributions, while allowing for
sample-to-sample variability and subpopulation-specific
patterns [111].
Challenge III: Mapping single cells to a reference atlas
Classifying cells into cell types or states is essential for
many secondary analyses. As an example, consider study-
ing and classifying how expression within a cell type
varies across different biological conditions (for differen-
tial expression analyses, see the “Challenge II: Defining
flexible statistical frameworks for discovering complex
differential patterns in gene expression” and data integra-
tion approach +S in Fig. 6). To put the results of such
studies on a map, reliable reference systems with a res-
olution down to cell states are required—and depending
on the research question at hand, even intermediate tran-
sition states might be of interest (see “Varying levels of
resolution”).
The lack of appropriate, available references has so far
implied that only reference-free approaches were con-
ceivable. Here, unsupervised clustering approaches were
the predominant option (see data integration approach
1S in Fig. 6). Method development for such unsuper-
vised clustering of cells has already reached a certain level
of maturity; for a systematic identification of available
techniques, we refer to the respective reviews [125–127].
However, unsupervised approaches involve manual
cluster annotation. There are two major caveats: (i) man-
ual annotation is a time-consuming process, which also
(ii) puts certain limits to the reproducibility of the results.
Cell atlases, as reference systems that systematically cap-
ture cell types and states, either tissue specific or across
different tissues, remedy this issue (see data integration
approach +X+S in Fig. 6). They will need to be able to
embed new data points into a stable reference framework
that allows for different levels of resolution and will have
to eventually capture transitional cell states that fall in
between clearly annotated cell clusters (see Fig. 1 for an
idea of what cell atlas type reference systems could look
like).
Lähnemann et al. Genome Biology           (2020) 21:31 Page 10 of 35
Table 3 Published cell atlases of whole tissues or whole organisms
Organism Scale of cell atlas Citation
Nematode (Caenorhabditis elegans) Whole organism at larval stage L2 [128]
Planaria (Schmidteamediterranea) Whole organism of the adult animal [129, 130]
Fruit fly (Drosophila melanogaster) Whole organism at embryonic stage [131]
Zebrafish Whole organism at embryonic stage [132, 133]
Frog (Xenopus tropicalis) Whole organism at embryonic stage [134]
Mouse Whole adult brain [135–137]
Mouse Whole adult organism [138, 139]
Status
See Table 3 for a list of cell atlas type references that have
recently been published. For human, similar endeavors as
for the mouse are under way, with the intention to raise a
Human Cell Atlas [5]. Towards this end, initial consortia
focus on specific organs, for example, the lung [140].
The availability of these reference atlases has led to the
active development of methods that make use of them in
the context of supervised classification of cell types and
states [141–147]. Also, the systematic benchmarking of
this dynamic field of tools has begun [148]. A field that
can serve as a source of further inspiration is flow/mass
cytometry, where several methods already address
the classification of high-dimensional cell type data
[149–152].
Open problems
Cell atlases can still be considered under active develop-
ment, with several computational challenges still open,
in particular referring to the fundamental themes from
above [5, 140, 153]. Here, we focus on the mapping of
cells or rather their molecular profiles onto stable exist-
ing reference atlases to further highlight the importance
of these fundamental themes. A computationally and sta-
tistically sound method for mapping cells onto atlases for
a range of conceivable research questions will need to (i)
enable operation at various levels of resolution of interest,
and also cover continuous, transient cell states (see “Vary-
ing levels of resolution”); (ii) quantify the uncertainty of
a particular mapping of cells of unknown type/state (see
“Quantifying uncertainty of measurements and analysis
results”); (iii) scale to ever more cells and broader cover-
age of types and states (see “Scaling to higher dimensiona-
lities: more cells, more features, and broader coverage”);
and (iv) eventually integrate information generated not
only through scRNA-seq experiments, but also through
other types of measurements, for example, scDNA-seq
or protein expression data (see “Challenge X: Integration
of single-cell data across samples, experiments, and types
of measurement” for a discussion of data integration,
especially approaches +M+C and +all in Fig. 6).
Finally, for further benchmarking of methods that map
cells of unknown type or state onto reference atlases
(see “Challenge XI: Validating and benchmarking analysis
tools for single-cell measurements” for benchmarking in
general), atlases of model organisms where full lineages of
cells have been determined can form the basis [129, 130,
132, 134, 154]. Importantly, additional information avail-
able from lineage tracing of such simpler organisms can
provide a cross-check with respect to the transcriptome
profile-based classification [134, 155].
Challenge IV: Generalizing trajectory inference
Several biological processes, such as differentiation,
immune response, or cancer expansion, can be described
and represented as continuous dynamic changes in cell
type/state space using tree, graphical, or probabilistic
models. A potential path that a cell can undergo in
this continuous space is often referred to as a trajec-
tory ([156] and Fig. 1), and the ordering induced by
this path is called pseudotime. Several models have
been proposed to describe cell state dynamics starting
from transcriptomic data [157]. Trajectory inference is
in principle not limited to transcriptomics. Neverthe-
less, modeling of other measurements, such as proteomic,
metabolomic, and epigenomic, or even integrating mul-
tiple types of data (see “Challenge X: Integration of sin-
gle-cell data across samples, experiments, and types of
measurement”), is still at its infancy. We believe the
study of complex trajectories integrating different data
types, especially epigenetics and proteomics information
in addition to transcriptomics data, will lead to a more
systematic understanding of the processes determining
cell fate.
Status
Trajectorymethods start from a countmatrix where genes
are rows and cells are columns. First, a feature selec-
tion or dimensionality reduction step is used to explore
a subspace where distances between cells are more reli-
able. Next, clustering and minimum spanning trees [156,
158], principal curve or graph fitting [159–161], or ran-
dom walks and diffusion operations on graphs ([162,
163] among others) are used to infer pseudotime and/or
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branching trajectories. Alternative probabilistic descrip-
tions can be obtained using optimal transport analysis
[164] or approximation of the Fokker-Planck equations
[165] or by estimating pseudotime through dimensionality
reduction with a Gaussian process latent variable model
[166–168].
Open problems
Many of the abovementioned methods for trajectory
inference can be extended to data obtained with non-
transcriptomic assays. For this, the following aspects are
crucial. First, it is necessary to define the features to use.
For transcriptomic data, the features are well annotated
and correspond to expression levels of genes. In contrast,
clear-cut features are harder to determine for data such
as methylation profiles and chromatin accessibility where
signals can refer to individual genomic sites, but also
be pooled over sequence features or sequence regions.
Second, many of those recent technologies only allow
measurement of a quite limited number of cells com-
pared to transcriptomic assays [169–171]. Third, some
of those measurements are technically challenging since
the input material for each cell is limited (for exam-
ple, two copies of each chromosome for methylation
or chromatin accessibility), giving rise to more spar-
sity than scRNA-seq. In the latter case, it is necessary
to define distance or similarity metrics that take this
into account. An alternative approach consists of pool-
ing/combining information from several cells or data
imputation (see “Challenge I: Handling sparsity in sin-
gle-cell RNA sequencing”). For example, imputation has
been used for single-cell DNA methylation [172], aggre-
gation over chromatin accessibility peaks from bulk or
pseudo-bulk sample [173], and k-mer-based approaches
have been proposed [160, 174, 175]. However, so far,
no systematic evaluation (see “Challenge XI: Validating
and benchmarking analysis tools for single-cell measure-
ments”) of those choices has been performed and it is not
clear how many cells are necessary to reliably define those
features.
A pressing challenge is to assess how the various tra-
jectory inference methods perform on different data types
and importantly to define metrics that are suitable. Also, it
is necessary to reason on the ground truth or propose rea-
sonable surrogates (e.g., previous knowledge about devel-
opmental processes). Some recent papers explore this idea
using scATAC-seq data, an assay to measure chromatin
accessibility [160, 174, 176].
Having defined robust methods to reconstruct trajec-
tories from each data type, another future challenge is
related to their comparison or alignment. Here, some
ideas from recent methods used to align transcriptomic
datasets could be extended [118, 177, 178]. A related
unsolved problem is that of comparing different trajec-
tories obtained from the same data type but across indi-
viduals or conditions, in order to highlight unique and
common aspects.
Challenge V: Finding patterns in spatially resolved
measurements
Single-cell spatial transcriptomics or proteomics [179–
181] technologies can obtain transcript abundance mea-
surements while retaining spatial coordinates of cells or
even transcripts within a tissue (this can be seen as an
additional feature space to integrate, see approach +M1C
in “Challenge X: Integration of single-cell data across sam-
ples, experiments, and types of measurement”, Fig. 6 and
Table 4).With such data, the question arises of how spatial
information can best be leveraged to find patterns, infer
cell types or functions, and classify cells in a given tissue
[182].
Status
Experimental approaches have been tailored either to sys-
tematically extract foci of cells and analyze them with
scRNA-seq, or to measure RNA and proteins in situ. His-
tological sections can be projected in two dimensions
while preserving spatial information using sequencing
arrays [183]. Whole tissues can be decomposed using
the Niche-seq approach [184]: here, a group of cells are
specifically labeled with a fluorescent signal, sorted and
subjected to scRNA-seq. The Slide-seq approach uses an
array of Drop-seq beads with known barcodes to dissolve
corresponding slide sites and sequence them with the
respective barcodes [185]. Ultimately, one would like to
sequence inside a tissue without dissociating the cells and
without compromising on the unbiased nature of scRNA-
seq. First approaches aiming to implement sequencing by
synthesis in situ were proposed by Ke et al. [186] and
Lee et al. [187], the latter being referred to as FISSEQ
(Fluorescent in situ sequencing). Recently, starMAP [188]
was presented. Here, RNA within an intact 3D tissue can
be amplified and transferred into a hydrogel. Within the
hydrogel, amplified DNA barcodes can be sequenced in
situ, in order to distinguish RNA species while retain-
ing spatial coordinates. Instead of performing a direct
identification of (parts of ) the RNA sequence, fluores-
cent in situ hybridization (FISH)-based methods require
to design probes for targeting RNA species of interest.
When multiplexing several rounds of FISH in combina-
tion with designed barcodes for each RNA species, it
becomes possible to measure hundreds to thousands of
RNA species simultaneously. Lubeck et al. [189] have
shown a first approach of multiplexed, barcoded FISH to
measure tens of RNA species simultaneously, called seq-
FISH. Later, MERFISH was proposed by Chen et al. [190],
which enabled the measurement of hundreds to thou-
sands of transcripts in single cells simultaneously while
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retaining spatial coordinates [191]. Subsequently, Shah et
al. [192] have scaled seqFISH to hundreds of RNA species
as well. This year, Eng et al. [193] presented SeqFISH+,
which scales the FISH barcoding strategy to 10,000 RNA
species by splitting each of 4 barcode locations to be
scanned into 20 separate readings to avoid optical sig-
nal crowding. The latter can also be an issue when fewer
RNA species are measured, in particular at densely pop-
ulated regions such as the nucleus [190]. To solve such
issues at the expense of measuring fewer RNA species,
Codeluppi et al. [194] have proposed osmFISH, which
uses a single fluorescent probe per RNA species and lever-
ages FISH iterations to measure different species instead
of building up a barcode. This leads to a number of rec-
ognizable RNA species that is linear in the number of
FISH iterations. In addition to the methods that provide
in situ measurements of RNA, mass cytometry [195, 196]
and multiplexed immunofluorescence [197–199] can be
used to quantify the abundance of proteins while preserv-
ing subcellular resolution. Finally, the recently described
Digital Spatial Profiling [200, DSP; 201] promises to pro-
vide both RNA and protein measurements with spatial
resolution.
For determining cell types, or clustering cells into
groups that conduct a common function, several methods
are available [147, 177, 202], but none of these currently
use spatial information directly. In contrast, spatial corre-
lation methods have been used to detect the aggregation
of proteins [203]. Shah et al. [204] use seqFISH to mea-
sure transcript abundance of a set of marker genes while
retaining the spatial coordinates of the cells. Cells are
clustered by gene expression profiles and then assigned
to regions in the brain based on their coordinates in the
sample. Recently, Esgärd et al. [205] presented a method
to detect spatial differential expression patterns per gene
based on marked point processes [206], and Svensson et
al. [207] provided amethod to perform a spatially resolved
differential expression analysis. Here, spatial dependence
for each gene is learned by non-parametric regression,
enabling the testing of the statistical significance for a gene
to be differentially expressed in space.
Open problems
The central problem is to consider gene or transcript
expression and spatial coordinates of cells, and derive
an assignment of cells to classes, functional groups, or
cell types. Depending on the studied biological question,
it can be useful to constrain assignments with expec-
tations on the homogeneity of the tissue. For example,
a set of cells grouped together might be required to
appear in one or multiple clusters where little to no
other cells are present. Such constraints might depend
on the investigated cell types or tissues. For example,
in cancer, spatial patterns can occur on multiple scales,
ranging from single infiltrating immune cells [208] and
minor subclones [209] to larger subclonal structures or
the embedding in surrounding normal tissue and the
tumor microenvironment [210]. Currently, to the best of
our knowledge, there is no method available that would
allow the encoding of such prior knowledge while infer-
ring cell types by integrating spatial information with
transcript or gene expression. The expected tissue het-
erogeneity therefore also impacts the desired properties
of the assignment method itself. For example, in order to
also recognize groups or types of interest that are expected
to occur at multiple locations, applicable methods should
not strictly rely on co-localization of transcriptional
profiles.
Another important aspect when modeling the rela-
tion between space and expression is whether uncertainty
in the measurements can be propagated to downstream
analyses. For example, it is desirable to rely on transcript
quantification methods that provide the posterior distri-
bution of transcript expression [102, 211] and propagate
this information to the spatial analysis. Since many spatial
measurement approaches entail an optical, microscopy-
based component, it would be beneficial to extract addi-
tional information from these measurements. For exam-
ple, cell shape and size, as well as the subcellular spatial
distribution of transcripts or proteins, could be used to
additionally guide the clustering or classification process.
Finally, in light of issues with sparsity in single-cell mea-
surements (see “Challenge I: Handling sparsity in sin-
gle-cell RNA sequencing”), it appears desirable to inte-
grate spatial information into the quantification itself, and,
for example, use neighboring cells within the same tissue
for imputation or the inference of a posterior distribution
of transcript expression.
Challenges in single-cell genomics
With every cell division in an organism, the genome can
be altered through mutational events ranging from point
mutations, over short insertions and deletions, to large
scale copy number variations and complex structural vari-
ants. In cancer, the entire repertoire of these genetic
events can occur during disease progression (Fig. 4). The
resulting tumor cell populations are highly heterogeneous.
As tumor heterogeneity can predict patient survival and
response to therapy [4, 212], including immunother-
apy, quantifying this heterogeneity and understanding its
dynamics are crucial for improving diagnosis and thera-
peutic choices (Fig. 4).
Classic bulk sequencing data of tumor samples taken
during surgery are always a mixture of tumor and nor-
mal cells (including invading immune cells). This means
that disentangling mutational profiles of tumor subclones
will always be challenging, which especially holds for rare
subclones that could nevertheless be the ones bearing
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Fig. 4 A tumor evolves somatically—from initiation to detection, to resection, and to possible metastasis. New genomic mutations can confer a
selective advantage to the resulting new subclone that allows it to outperform other tumor subclones (subclone competition). At the same time,
the acting selection pressures can change over time (e.g., due to new subclones arising, the immune system detecting certain subclones, or as a
result of therapy). Understanding such selective regimes—and how specific mutations alter a subclone’s susceptibility to changes in selection
pressures—will help construct an evolutionary model of tumorigenesis. And it is only within this evolutionary model that more efficient and more
patient-specific treatments can be developed. For such a model, unambiguously identifying mutation profiles of subclones via scDNA-seq of
resected or biopsied single cells is crucial
resistance mutation combinations prior to a treatment.
Here, the sequencing of single cells holds the exciting
promise of directly identifying and characterizing those
subclone profiles (Fig. 4).
Ideally, scDNA-seq should provide information about
the entire repertoire of distinct events that occurred
in the genome of a single cell, such as copy number
alterations and genomic rearrangements, together with
SNVs and smaller insertion and deletion variants. How-
ever, scDNA-seq requires WGA of the DNA extracted
from single cells and this amplification introduces errors
and biases that present a serious challenge to variant
calling [213–216]. It is broadly accepted that different
WGA technologies should be used to detect different
types of variation. PCR-based approaches [217–220] are
best suited for CNV calling, as they achieve a more
uniform coverage. But they require thermostable poly-
merases that withstand the temperature maxima during
PCR cycling, and all such polymerases have relatively high
error rates. In contrast, MDA-based techniques are the
method of choice for SNV calling, as they achieve much
lower error rates with the high-fidelity 29 DNA poly-
merase [31, 221–225] (in an isothermal reaction, as it
would not be stable at common PCR temperature max-
ima). But MDA suffers from stronger allelic bias in the
amplification, possibly because it is more sensitive to
DNA input quality [226] and biased priming [227]. The
goal must thus be to (i) improve the coverage unifor-
mity of MDA-based methods, (ii) reduce the error rate
of the PCR-based methods, or (iii) create new methods
that exhibit both a low error rate and a more uniform
amplification of alleles. Recent years witnessed inten-
sive research in these directions (see Table 1), promising
scalable methodology for scDNA-seq comparable to that
already available for scRNA-seq, while at the same time
reducing previously limiting errors and biases. While this
is not a SCDS challenge, it remains central to contin-
uously and systematically evaluate the whole range of
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promisingWGAmethods for the identification of all types
of genetic variation from SNVs over smaller insertions
and deletions up to copy number variation and structural
variants.
Challenge VI: Dealing with errors andmissing data in the
identification of variation from single-cell DNA sequencing
data
The aim of scDNA-seq usually is to track somatic evolu-
tion at the cellular level, that is, at the finest resolution
possible relative to the laws of reproduction (cell divi-
sion, Fig. 5). Examples are identifying heterogeneity and
tracking evolution in cancer, as the likely most predomi-
nant use case (also see below in “Challenges in single-cell
phylogenomics”), but also monitoring the interaction of
somatic mutation with developmental and differentiation
processes. To track genetic drifts, selective pressures, or
other phenomena inherent to the development of cell
clones or types (Fig. 4)—but also to stratify cancer patients
for the presence of resistant subclones—it is instrumental
to genotype and also phase genetic variants in single cells
with sufficiently high confidence.
The major disturbing factor in scDNA-seq data is the
WGA process (see above). All methodologies introduce
amplification errors (false positive alternative alleles), but
more drastic is the effect of amplification bias: the insuf-
ficient or complete failure of amplification, which leads to
Fig. 5 Mutations (colored stars) accumulate in cells during somatic
cell divisions and can be used to reconstruct the developmental
lineages of individual cells within an organism (leaf nodes of the tree
with mutational presence/absence profiles attached). However,
insufficient or unbalanced WGA can lead to the dropout of one or
both alleles at a genomic site. This can be mitigated by better
amplification methods, but also by computational and statistical
methods that can account for or impute the missing values
imbalanced proportions or complete lack of variant alle-
les. Overall, one can distinguish between three cases: (i) an
imbalanced proportion of alleles, i.e., loci harboring het-
erozygous mutations where preferential amplification of
one of the two alleles leads to distorted read counts; (ii)
allele dropout, i.e., loci harboring heterozygous mutations
where only one of the alleles was amplified and sequenced;
and (iii) site dropout, which is the complete failure of
amplification of both alleles at a site and the resulting lack
of any observation of a certain position of the genome.
Note that (ii) can be considered an extreme case of (i).
A sound imputation of missing alleles and a sufficiently
accurate quantification of uncertainties will yield mas-
sive improvements in geno- and haplotyping (phasing)
somatic variants. This, in turn, is necessary to substan-
tially improve the identification of subclonal genotypes
and the tracking of evolutionary developments. Poten-
tial improvements in this area include (i) more explicit
accounting for possible scDNA-seq error types, (ii) inte-
grating with different data types with error profiles dif-
ferent from scDNA-seq (e.g., bulk sequencing or RNA
sequencing), or (iii) integrating further knowledge of the
process of somatic evolution, such as the constraints of
phylogenetic relationships among cells, into variant call-
ing models. In this latter context, it is important to realize
that somatic evolution is asexual. Thus, no recombina-
tion occurs during mitosis, eliminating a major disturb-
ing factor usually encountered when aiming to recon-
struct species or population trees from germline mutation
profiles.
Status
Current single cell-specific SNV callers include Mono-
var [228], SCcaller [229], and SCAN-SNV [230]. SCcaller
detects somatic variants independently for each cell, but
accounts for local allelic amplification biases by integrat-
ing across neighboring germline single-nucleotide poly-
morphisms. It exploits the fact that allele dropout affects
contiguous regions of the genome large enough to har-
bor several, and not only one, heterozygous mutation loci.
SCAN-SNV works along similar lines, fitting a region-
specific allelic balance model to germline heterozygous
variants called in a reference bulk sample. Monovar uses
an orthogonal approach to variant calling. It does not
assume any dependency across sites, but instead handles
low and uneven coverage and false positive alternative
alleles by integrating the sequencing information across
multiple cells. While Monovar merely creates a consensus
across cells, integrating across cells is particularly power-
ful if further knowledge about the dependency structure
among cells is incorporated. As pointed out above, due
to the lack of recombination, any sample of cells derived
from an organism shares an evolutionary history that can
be described by a cell lineage tree (see “Challenges in
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single-cell phylogenomics”). This tree, however, is in gen-
eral unknown and can in turn only be reconstructed from
single-cell mutation profiles. A possible solution is to infer
both mutation calls and a cell lineage tree at the same
time, an approach taken by a number of existing tools:
single-cell Genotyper [231], SciCloneFit [232], and Sci
[233]. Finally, SSrGE identifies SNVs correlated with gene
expression from scRNA-seq data [234].
Some basic approaches to CNV calling from scDNA-
seq data are available. These are usually based on hid-
den Markov models (HMMs) where the hidden variables
correspond to copy number states, as, for example, in
Aneufinder [235]. Another tool, Ginkgo, provides inter-
active CNV detection using circular binary segmentation,
but is only available as a web-based tool [236]. ScRNA-seq
data, which does not suffer from the errors and biases of
WGA, can also be used to call CNVs or loss of heterozy-
gosity events: an approach called HoneyBADGER [237]
utilizes a probabilistic hidden Markov model, whereas the
R package inferCNV simply averages the expression over
adjacent genes [238].
Open problems
SNV callers for scDNA-seq data have already incorpo-
rated amplification error rates and allele dropout in their
models. Beyond these rates, the challenge remains to
further extend this by directly modeling the amplifica-
tion process using statistics that would inherently account
for both errors and biases, and more accurately quantify
the resulting uncertainties (see “Quantifying uncertainty
of measurements and analysis results”). This could be
achieved by expanding models that accurately quantify
uncertainties in related settings [239] and would ulti-
mately even allow reliable control of false discovery rates
in the variant discovery and genotyping process. Such
expanded models can build on a number of recent stud-
ies in this context, for example, on a formalization in a
recent preprint [240]. Furthermore, such models could
integrate the structure of cell lineage trees with the struc-
ture implicit in haplotypes that link alleles. For haplotype
phasing, Satas and Raphael [241] recently proposed an
approach based on contiguous stretches of amplification
bias (similar to SCcaller, see above), whereas others pro-
pose read-backed phasing in two recent studies [242, 243].
In addition, the integration with deep bulk sequencing
data, as well as with scRNA-seq data, remains unexplored,
although it promises to improve the precision of callers
without compromising sensitivity.
Identification of short insertions and deletions (indels)
is another major challenge to be addressed: we are not
aware of any scDNA-seq variant callers with those respec-
tive capabilities.
For copy number variation calling, software has previ-
ously been published mostly in conjunction with data-
driven studies. Here, a systematic analysis of biases in the
most common WGA methods for copy number variation
calling (including newer methods to come) could fur-
ther informmethod development. The already mentioned
approach of leveraging amplification bias for phasing
could also be informative [241].
The final challenge is a systematic comparison of tools
beyond the respective software publications, which is still
lacking for both SNV and CNV callers. This requires sys-
tematic benchmarks, which in turn require simulation
tools to generate synthetic datasets, as well as real sample-
based benchmarking datasets with a reasonably reliable
ground truth (see “Challenge XI: Validating and bench-
marking analysis tools for single-cell measurements”).
Challenges in single-cell phylogenomics
Single-cell variation profiles from scDNA-seq, as
described above (“Challenge VI: Dealing with errors
and missing data in the identification of variation
from single-cell DNA sequencing data”), can be used in
computational models of somatic evolution, including
cancer evolution as an important special case (Fig. 4).
For cancer, there is an ongoing, lively discussion about
the very nature of evolutionary processes at play, with
competing theories such as linear, branching, neutral, and
punctuated evolution [244].
Models of cancer evolution may range from a simple
binary representation of the presence versus the absence
of a particular mutational event (Fig. 5), to elaborate mod-
els of the mechanisms and rates of distinct mutational
events. There are two main modeling approaches that
lend themselves to the analysis of tumor evolution [245]:
phylogenetics and population genetics.
Phylogenetics comes with a rich repertoire of compu-
tational methods for likelihood-based inference of phylo-
genetic trees [246]. Traditionally, these methods are used
to reconstruct the evolutionary history of a set of dis-
tinct species. However, they can also be applied to cancer
cells or subclones (Fig. 4). In this setting, tips of the phy-
logeny (also called leaves or taxa) represent sampled and
sequenced cells or subclones, whereas inner nodes (also
called ancestral) represent their hypothetical common
ancestors. The input for a phylogenetic inference com-
monly consists of a multiple sequence alignment (MSA) of
molecular sequences for the species of interest. For cancer
phylogenies, one would concatenate the SNVs (and possi-
bly other variant types) to assemble the input MSA. The
key challenge for phylogenetic method development com-
prises designing sequence evolution models that are (i)
biologically realistic and yet (ii) computationally tractable
for the increasingly large number of sequenced cells per
patient and study.
In population genetics, the tumor is understood as a
population of evolving cells (Fig. 4). To date, population
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genetic theory has been used to model the initiation,
progression, and spread of tumors from bulk sequenc-
ing data [247–249]. The general mathematical framework
behind these models are branching processes [250], for
example, in models of the accumulation of driver and
passenger mutations [251, 252]. Here, the driver muta-
tions carry a fitness advantage, as might epistatic interac-
tions among them [253]. In contrast, passenger mutations
are assumed to be neutral regarding fitness; they merely
hitchhike along the fitness advantage of driver mutations
they are linked to via their haplotype. The parameters
of population genetic models describe inherent features
of individual cells that are relevant for the evolution of
their populations, for example, fitness and the rates of
birth, death, and mutations. Such cell-specific parame-
ters should more naturally apply to and be derived from
information gathered by sequencing of individual cells,
as opposed to sequencing of bulk tissue samples. Mod-
els using these parameters will, for example, be essen-
tial in the design of adaptive cancer treatment strate-
gies that aim at managing subclonal tumor composition
[254, 255].
Challenge VII: Scaling phylogenetic models to many cells
andmany sites
Even if given perfect data, phylogenetic models of tumor
evolution would still face the challenge of computational
tractability, which is mainly induced by (i) the increasing
numbers of cells that are sequenced in cancer studies and
(ii) the increasing numbers of sites that can be queried
per genome (see “Scaling to higher dimensionalities: more
cells, more features, and broader coverage”).
Open problems
(i) While adding data from more single cells will help
improve the resolution of tumor phylogenies [256, 257],
this exacerbates one of the main challenges of phyloge-
netic inference in general: the immense space of possible
tree topologies that grows super-exponentially with the
number of taxa—in our case the number of single cells.
Phylogenetic inference is NP-hard [258] under most scor-
ing criteria (a scoring criterion takes a given tree andMSA
to calculate how well the tree explains the observed data).
Calculating the given score on all possible trees to find
the tree that best explains the data is computationally not
feasible for MSAs containing more than approximately
20 single cells, and thus requires heuristic approaches
to explore only promising parts of the tree search
space.
(ii) In addition to the growing number of cells (taxa),
the breadth of genomic sites and genomic alterations
that can be queried per genome also increases. Classical
approaches thus need not only scale with the number of
single cells queried (see above), but also with the length
of the input MSA. Here, previous efforts for paralleliza-
tion [259, 260] and other optimization efforts [261] exist
and can be built upon. The breadth of sequencing data
also allows determination of large numbers of invariant
sites, which further raises the question of whether includ-
ing them will change results of phylogenetic inferences in
the context of cancer. Excluding invariant sites from the
inference has been coined ascertainment bias. For phylo-
genetic analyses of closely related individuals from a few
populations, it has been shown that accounting for ascer-
tainment bias alters branch lengths, but not the resulting
tree topologies per se [262].
Challenge VIII: Integrating multiple types of variation into
phylogenetic models
Naturally, downstream analyses—like characterizing
intratumoral heterogeneity and inferring its evolutionary
history—suffer from the unreliable variant detection in
single cells. However, the better the quality of the variant
calls becomes, the more important it becomes to model
all types of available signal in mathematical models of
tumor evolution: from SNVs, over smaller insertions and
deletions, to large structural variation and CNVs (Fig. 4).
In turn, this should increase the resolution and reliability
of the resulting trees.
Status
For phylogenetic tree inference from SNVs of single cells,
a considerable number of tools exist. The early tools
OncoNEM [263] and SCITE [264] use a binary represen-
tation of presence or absence of a particular SNV. They
account for false negatives, false positives, and missing
information in SNV calls, where false negatives are orders
of magnitude more likely to occur than false positives.
The more recent tool SiFit [265] also uses a binary SNV
representation, but infers tumor phylogenies allowing for
both noise in the calls and for violations of the infinite
sites assumption2. Another approach allowing for viola-
tions of the infinite sites assumption is the extension of
the Dollo parsimony model to allow for k losses of a
mutation (Dollo-k) [266, 267]. Single-cell genotyper [231],
SciCloneFit [232], or Sci [233] jointly call mutations
in individual cells and estimate the tumor phylogeny of
these cells, directly from single-cell raw sequencing data.
In a recent work [268], a standard phylogenetic infer-
ence tool RAxML-NG [269] has been extended to han-
dle single-cell SNV data. In particular, this implements
(i) a 10-state substitution model to represent all possi-
ble unphased diploid genotypes and (ii) an explicit error
model for allelic dropout and genotyping/amplification
errors. Initial experiments showed that—although a 10-
state model incorporates more information—it outper-
2The infinite sites assumption posits a genome with an infinite number of
sites, thus rendering a repeated mutational hit of the same genomic site along
a phylogeny impossible.
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formed the ternary model (as used by SiFit) only slightly
and only in simulations with very high error rates (10–
50%). However, further analysis suggests that benefits
of the genotype model become much more pronounced
with an increasing number of cells and, in particular,
an increasing number of SNVs (preliminary analysis by
Kozlov).
While there are no tools yet available to identify inser-
tions and deletions from scDNA-seq (see “Challenge VI:
Dealing with errors and missing data in the identifica-
tion of variation from single-cell DNA sequencing data”),
it is only a matter of time until such callers will become
available. As they can already be identified from bulk
sequencing data, some precious efforts to incorporate
indels in addition to substitutions into classical phylo-
genetic models exist: A decade ago, a simple probabilis-
tic model of indel evolution was proposed [270]. But
although some progress has been made since then, such
models are less tractable than the respective substitution
models [271].
Incorporating CNVs in the reconstruction of tumor
phylogeny can be helpful for understanding tumor pro-
gressions, as they represent one of the most common
mutation types associated to tumor hypermutability [272].
CNVs in single cells were extensively studied in the con-
text of tumor evolution and clonal dynamics [273, 274].
Reconstructing a phylogeny with CNVs is not straight-
forward. The challenges not only are related to experi-
mental limits, such as the complexity of bulk sequencing
data [275] and amplification biases [276], but also involve
computational constraints. First of all, the causal mech-
anisms, such as breakage-fusion-bridge cycles [277] and
chromosome missegregation [278], can lead to overlap-
ping copy number events [279]. Secondly, inferring a
phylogeny with CNV data requires quantifying biolog-
ically motivated transition probabilities for changes in
copy numbers. Towards that goal, approaches to calculate
the distance between whole copy number profiles [280]
are a first step. But for them, a number of challenges
remain, with several of the underlying problems known to
be NP-hard [280].
Co-occurrence of all of the above variation types fur-
ther complicates mathematical modeling, as these events
are not independent. For example, multiple SNVs that
occurred in the process of tumor evolution may disap-
pear at once via a deletion of a large genomic region. In
addition, recent analyses revealed recurrence and loss of
particular mutational hits at specific sites in the life his-
tories of tumors [281]. This undermines the validity of
the so-called infinite sites assumption, commonlymade by
phylogenetic models.
Open problems
For phylogenetic reconstruction from SNVs, we anticipate
a shift towards leveraging improvements in input data
quality as they are achieved through better amplification
methods and SNV callers (see Table 1 and “Challenge VI:
Dealing with errors and missing data in the identifica-
tion of variation from single-cell DNA sequencing data”).
For indels, variant callers for scDNA-seq data are antic-
ipated but remain to be developed (see “Challenge VI:
Dealing with errors and missing data in the identifica-
tion of variation from single-cell DNA sequencing data”).
Thus, indel modeling efforts for phylogenetic reconstruc-
tion from bulk sequencing data should be adapted. For
phylogenetic inference from CNVs, the major challenges
are (i) determining correct mutational profiles and (ii)
computing realistic transition probabilities between those
profiles.
The final problem will be to incorporate all of the above
phenomena into a holistic model of cancer evolution.
However, this will substantially increase the computa-
tional cost of reconstructing the evolutionary history of
tumor cells. Thus, one needs to carefully determine which
phenomena actually do matter (e.g., which parameters
even affect the final tree topology) and which features can
be measured and called (see “Challenge VI: Dealing with
errors and missing data in the identification of variation
from single-cell DNA sequencing data”) with sufficient
accuracy to actually improve modeling results. As a con-
sequence, one might be able to devise more lightweight
models for answering specific questions and invest con-
siderable effort into optimizing novel tools at the algo-
rithmic and technical level (see “Challenge IX: Inferring
population genetic parameters of tumor heterogeneity by
model integration”).
Challenge IX: Inferring population genetic parameters of
tumor heterogeneity by model integration
Tumor heterogeneity is the result of an evolutionary jour-
ney of tumor cell populations through both time and
space [209, 212]. Microenvironmental factors like access
to the vascular system and infiltration with immune cells
differ greatly—for regions within the original tumor as
well as between the main tumor and metastases, and
across different time points [282]. This imposes differ-
ent selective pressures on different tumor cells, driv-
ing the formation of tumor subclones and thus deter-
mining disease progression (including metastatic poten-
tial), patient outcome, and susceptibility to treatment
([283, 284] and Fig. 4). However, even the basic ques-
tions about the resulting dynamics remain unanswered
[285]. For example, it is unclear whether metastatic seed-
ing from the primary tumor occurs early and multi-
ple times in parallel (with metastases diverging geneti-
cally from the primary tumor), or whether seeding of
metastases occurs late, from a far-developed subclone
in the primary tumor (seeding multiple locations with a
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genotype closer to the late-stage primary tumor). More-
over, it is unknown whether a single cell can seed a
metastasis, or whether the joint migration of a set of
cells is required. Here, sc-seq can provide invaluable
resolution [273].
Although many mathematical models of tumor evo-
lution have been proposed [245, 247, 251, 252, 286,
287], fundamental parameters characterizing the evo-
lutionary processes remain elusive. To quantitatively
describe the tumor evolution process and evaluate dif-
ferent possible modes against each other (e.g., modes
of metastatic seeding), we would like to estimate fit-
ness values of individual mutations and mutation com-
binations, as well as rates of mutation, cell birth, and
cell death—if possible, on the level of subclones. These
parameters determine the underlying fitness landscape
of individual cells within their microenvironment, which
in turn determines the evolutionary dynamics of cancer
progression.
Status
Recent technological advances already allow for measur-
ing the arrangement and relationships of tumor cells in
space, with cell location basically amounting to a sec-
ond measurement type requiring data integration within
a cell (approach +M1C in “Challenge X: Integration of sin
gle-cell data across samples, experiments, and types of
measurement”, Fig. 6, and Table 4). While in vivo imag-
ing techniques might also become interesting for obtain-
ing time series data in the future [288], the automated
analysis of whole slide immunohistochemistry images
[289, 290] seems the most promising in the context of
cancer and mutational profiles from scDNA-seq. It is
already amenable to single-cell extraction of characterized
cells with known spatial context and subsequent scDNA-
seq. Using laser capture microdissection [291], hundreds
of single cells have recently been isolated from tissue
sections and analyzed for copy number variation [292].
For cell and tissue characterization in immunohistochem-
ical images, machine learning models are trained to seg-
ment the images and recognize structures within tissues
and cells [293–295]: They can, for example, determine the
densities and quantities of mitotic nuclei, vascular inva-
sion, and immune cell infiltration on the tissue level, as
well as stained biomarkers on the level of the individual
cell. These are key parameters of the tumor microen-
vironment, characterizing the interaction of tumor cells
with their environment in space [296, 297], that are
key to mathematical models of cancer evolution. Devel-
opment of reliable classifiers for immunohistochemical
images, however, is challenging due to scarcity of training
data. Solutions such as active learning can speed up the
training process and reduce the workload of annotating
pathologists [298].
Classically, mathematical models of tumor population
genetics have assumed well mixed populations, ignoring
any spatial structure, let alone evolutionarymicroenviron-
ments. Recently, methods have been extended to account
for some spatial structure and have already led to refined
predictions of the waiting time to cancer [299] and intra-
tumor heterogeneity [300]. In particular, spatial statistics
have been proposed for the quantitative statistical analy-
sis of cancer digital pathology imaging [297], but the idea
is applicable to other spatially resolved readouts. Further,
a number of methods were proposed to model cell-cell
interactions [301, 302] or to predict single-cell expression
from microenvironmental features [199, 303].
Regarding temporal resolution, it is already common
to sequence tumor material from different time points:
biopsies used for diagnosis, resected tumors, lymph
nodes and metastases upon surgery, and tumors after
relapse. These time points already lend themselves to
temporal analyses of clonal dynamics using bulk DNA
sequencing data [304], but scDNA-seq is required for
a higher resolution of subclonal genotypes. In addition,
time resolved measurements and resulting proliferation
and death rates promise a higher accuracy in detecting
epistatic interactions in cancer genomes than available
from previous analyses of bulk sequenced tumor genomes
[305–308].
Eventually, population genetic methods and models
should be integrated with approaches from phylogenet-
ics, to also leverage the kinship relationships between
cells. One prominent example of this recent trend—albeit
on bulk data—is the use of the multi-species coalescent
model for analyzingMSAs that contain several individuals
for several populations [309, 310]. This naturally trans-
lates into analyzing tumor subclones as populations of sin-
gle cells, capturing some of the population structure seen
in cancers. Another recent example is a computational
model for inference of fitness landscapes of cancer clone
populations using scDNA-seq data, SCIFIL [311]. It esti-
mates the maximum likelihood fitness of clone variants by
fitting a replicator equation model onto a character-based
tumor phylogeny.
For a comprehensive integration, key parameters will
need to be quantified with higher resolution. For the
detection of positive selection—for example, important in
the discussion whether the evolution of tumors is driven
by selection or neutral—a number of phylogenetic and
population genetic approaches have been proposed in a
bulk context. Phylogenetic trees may be used for detecting
branches on which positive [312] or diversifying episodic
selection [313] is acting.
In this setting, we will have to account for heterotachy
(e.g., [314]), that is, we cannot assume a single model of
substitution for the entire tree, but have to allow different
models to act on distinct branches or subtrees/subclones.
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Here, anything from a simple model of rate heterogene-
ity (e.g., [315]) to an empirical mixture model as used for
protein evolution [316] could be considered.
Open problems
With an increased resolution of scDNA-seq (see “Chal-
lenges in single-cell genomics”, Table 1) and more work on
the scDNA-seq challenges described in other sections, it
will be possible to determine subclone genotypes in more
detail. The first challenge will be to integrate this with
the spatial location of single cells obtained from other
measurements. This will enable determining whether cells
from the same subclones are co-located, whether metas-
tases are founded recurrently by the same subclone(s), and
whether individual metastases are founded by individual
or multiple subclones. Studies utilizing multiple region
samples from the same tumor and from distantmetastases
already paved the way in investigating these questions
(e.g., [285]). Still, only single-cell spatial resolution will
allow identification of specific individual genotypes in
specific locations and drawing precise conclusions.
In addition, it will become possible to determine
subclone-specific model parameters and their variability
in more detail. For example, rates of proliferation, muta-
tion, and death could be obtained by measuring numbers
of mitotic and apoptotic cells per subclone or by integrat-
ing subclone abundance profiles across time points. Good
estimates of these basic parameters will greatly benefit
the detection of positive and negative selection in cancer,
and improve the prediction of subclone resistance (and
thus expected treatment success) from subclone fitness
estimates. The fitness of individual subclones could be
calculated from comparing expanded subclones in drug
screens under different treatment regimes.
Fig. 6 Approaches for integrating single-cell measurement datasets across measurement types, samples, and experiments, as also described in
Table 4. 1S: clustering of cells from one sample from one experiment requires no data integration. +S: integration of one measurement type across
samples requires the linking of cell populations/clusters. +X+S: integration of one measurement type across experiments conducted in separate
laboratories requires stable reference systems like cell atlases (compare Fig. 1). +M1C: integration of multiple measurement types obtained from the
same cell highlights the problem of data sparsity of all available measurement types and the dependency of measurement types that needs to be
accounted for. +M+C: integration of different measurement types from different cells of the same cell population requires special care in matching
cells through meaningful profiles. +all: one possibility for easing data integration across measurement types from separate cells would be to have
a stable reference (cell atlas) across multiple measurement types, capturing different cell states, cell populations, and organisms. Effectively, this
combines the challenges and promises of the approaches +X+S, +M1C, and +M+C
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For some of the rates, for example, subclone-specific
rates of mutation, the integration of models from popula-
tion genetics and phylogenetics holds promise and poses a
genuine SCDS challenge. But for all of these rates, having
better estimates implies follow-up challenges.
One of these resulting challenges will be to detect
positive or diversifying selection with greater resolution,
building on approaches from the bulk context. Here, tests
from the area of “classic” phylogenetics might serve as
a starting point for exploring and adapting appropriate
methods that will allow to associate positive selection
events to branches of the tumor tree or specific evolution-
ary events. Evolutionary pressures are often quantified
by the dN/dS ratio of non-synonymous and synonymous
substitutions. In application to tumor cell populations,
however, this ratio may not be applicable, as it has been
shown to be relatively insensitive when applied to pop-
ulations within the same species [317]. Other measures
have been proposed as better suited for detecting selec-
tion within populations based on time series data [318–
320] and could potentially be transferred to tumor cell
populations.
A particular problem with the detection of positive or
diversifying selection is to which extent the above tests
will be sensitive to errors in cancer data—the tests are
already known to produce high false positive rates in the
classic phylogenetic setting when the error rate in the
input data is too high [321]. Computationally intense solu-
tions for decreasing the high false positive rate have been
proposed [322], but they might not scale to single-cell
cancer datasets.
Another resulting problem will be to adapt models for
the detection of epistatic interactions to single-cell data.
As some of these epistatic interactions can be hard to
spot in bulk sequencing data (they may simply disappear
because of a low frequency), time-resolved scDNA-seq
might be the only way to spot them. If integrated across
individuals and cells (see “Challenge X: Integration of sin-
gle-cell data across samples, experiments, and types of
measurement”), it will be possible to identify pairs or even
larger combinations of mutations that often occur simul-
taneously in the same genome, and combinations that
rarely or never do. That is, cells affected by negatively
selected or synthetic lethal mutations will go extinct in
the tumor population, and thus, their genotype with the
synthetic lethal mutations occurring together will not be
observed. At the same time, cell death can be the result
of mere chance, so to detect significant negative pres-
sures, large cohorts of repeated time resolved experiments
would have to be performed, resulting in an even larger
data integration challenge (see “Challenge X: Integration
of single-cell data across samples, experiments, and types
of measurement”).
A final step will then be to integrate all these parameters
with further information about local microenvironments
(such as vascular invasion and immune cell infiltration),
to estimate the selection potential of such local factors for
or against different subclones.
Overarching challenges
Challenge X: Integration of single-cell data across samples,
experiments, and types of measurement
Biological processes are complex and dynamic, varying
across cells and organisms. To comprehensively analyze
such processes, different types of measurements from
multiple experiments need to be obtained and integrated.
Depending on the actual research question, such experi-
ments can be different time points, tissues, or organisms.
For their integration, we need flexible but rigorous statis-
tical and computational frameworks. Figure 6 and Table 4
provide an overview of the promises and challenges of cre-
ating such frameworks that we outline here in terms of six
approaches of data integration3. All of these approaches
are affected by the issues that influence single-cell data
analysis in general, namely (i) the varying resolution lev-
els that are of interest depending on the research question
at hand (see “Varying levels of resolution”), (ii) the uncer-
tainty of any measurements and how to quantify them for
and during the analyses (see “Quantifying uncertainty of
measurements and analysis results”), and (iii) the scaling
of single-cell methodology tomore cells andmore features
measured at once (see “Scaling to higher dimensionali-
ties: more cells, more features, and broader coverage”).
All of these further compound the most important chal-
lenge in the integration of single-cell data: to link data
from different sources in a way that is biologically mean-
ingful and supports the intended analysis. The maps that
describe how data from different sources is linked will
increase in complexity on increasing amounts of samples,
time points, and types of measurements.
In the simplest setup, we obtain one measurement type
from multiple cells of a single sample, to identify sub-
populations of cells (e.g., subclones or cell types). As any
analysis of sc-seq data, it needs to take into account the
data’s sparsity (see “Challenge I: Handling sparsity in sin-
gle-cell RNA sequencing” and “Challenge VI: Dealing with
errors and missing data in the identification of variation
from single-cell DNA sequencing data”; approach 1S in
Fig. 6 and Table 4).
When aiming at identifying patterns of differential
expression or characterizing variability across organisms,
individuals, or locations, the same measurement type (for
example, only scRNA-seq) is taken from multiple samples
from different time points, different locations (e.g., dif-
ferent tissues or sites in a tumor), or different organisms
3Graph representation in Fig. 6 approaches +X+S and +all taken from [14],
Fig. 3, provided under Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/)
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(approach +S). Any such combination of samples requires
accounting for batch effects among those samples and
calls for a validation cell type assignments across samples.
Such batch effects are further aggravated when integrat-
ing across multiple experiments, possibly run in differ-
ent experimental centers with similar but distinct setups
(approach +X+S). But standardizing experimental proce-
dures and statistically accounting for batch effects will
be well worth the effort wherever this enables a signif-
icant increase in sample size, so as to generalize (and
statistically corroborate) observations. Nevertheless, even
if standards have been successfully established and known
batches accounted for, additional validation of, for exam-
ple, assignments of cells to types and states may be
required. Eventually, an increase in generality will sup-
port the construction of reference systems, such as a cell
atlas, the existence of which can support decisive speed-
ups when classifying cells or cell states in subsequent
experiments (see “Challenge III: Mapping single cells to a
reference atlas”).
Yet another scenario manifests when trying to unravel
complexity and coordination of intracellular biological
processes, as well as their mutual dependencies, so as to
draw a comprehensive picture of a single cell. Here, an
optimal setup is to collect several types of measurements
from each cell at once; for example, both scDNA-seq and
scRNA-seq captured from the same cell, possibly further
augmented by measurements of chromatin accessibil-
ity, gene methylation, proteins, or metabolites (approach
+M1C). The most prominent challenge for this setup is
to model inherent dependencies between measurement
types wherever phenomena are concurrent (e.g., mea-
suring CNV through scDNA-seq at the same time as
obtaining scRNA-seq, with CNV impacting transcription
levels).
However, co-measuring different types of quantities in
the same cell can be experimentally challenging or even
just impossible at this point in time. An exit strategy to
this problem is to analyze a population of cells that is
homogeneous in terms of some cell type or state, tak-
ing different measurement types in different single cells
(approach +M+C). After collecting different measurement
types in different single cells, one needs to combine the
data in a way that is biologically meaningful. An example
is to group cells based on commonalities in their geno-
type profile (Fig. 6), having become evident only after the
application of a scDNA-seq experiment. This will require
careful validation of the assumptions made when match-
ing cells via such a grouping, possibly including functional
validation of group differences.
Finally, the most comprehensive goal will be a holis-
tic view of the complexity of (intra-)cellular circuits, and
charting their variability across time, tissues, populations,
and organisms (approach +all). Mapping cellular cir-
cuits in this comprehensive manner requires integrating
complementary and possibly interdependent measure-
ments in single cells and across multiple single cells from
diverse samples.
Status
For unsupervised clustering (approach 1S in Fig. 6 and
Table 4), method development is a well-established field.
Remaining challenges have already been identified sys-
tematically (see [125–127]).
For integrating datasets across samples in one experi-
ment (approach +S), a few approaches are available. See
for example MNN [118], and the methodologies included
in the Seurat package [177, 323, 324]. For the challenges
and promises referring to the integration of sc-seq data
that vary in terms of spatial and temporal origin, see the
discussions in “Challenge V: Finding patterns in spatially
resolved measurements” and “Challenge IX: Inferring
population genetic parameters of tumor heterogeneity by
model integration”.
For integrating datasets across experiments (approach
+X+S), mapping cells to reference datasets such as the
Human Cell Atlas [5] is currently emerging as the most
promising strategy. We refer the reader to more partic-
ular and detailed discussions in “Challenge III: Mapping
single cells to a reference atlas”. While applicable refer-
ence systems are not (fully) available, assembling cell type
clusters from different experiments is a reasonable strat-
egy, as implemented by several recently published tools
[202, 325–332].
Integrating across multiple measurement types from
the same cell (approach +M1C) has become necessary
(and possible) with the advent of experimental protocols
that enable the collection of such data [333]. Such pro-
tocols combine scDNA-seq and scRNA-seq [333–335];
methylation data and scRNA-seq [336]; all of scRNA-seq,
scDNA-seq, methylation, and chromatin accessibility data
[41]; or targeted queries on a cell’s genotype, expression
(scRNA-seq), and methylation status (sc-GEM [337]). For
these single cell-specific approaches, bulk approaches that
address the integration of data from different types of
experiments have the potential to be adapted to single cell-
specific noise characteristics (MOFA [92], DIABLO [338],
mixOmics [339], and MINT [340]).
For integrating across multiple measurement types from
separate cells (approach +M+C), all of which stem from
a population of cells that is homogeneous with respect
to some selection criterion, technologies such as 10X
genomics [171] for scRNA-seq and direct library prepa-
ration (DLP [341]) for scDNA-seq establish a scalable
experimental basis. The greater analytical challenge is to
identify subpopulations that had so far remained invisible,
and whose identification is crucial so as to not combine
different types of data in mistaken ways. An example for
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this is the identification of distinct cancer clones from
cells sampled from seemingly homogeneous tumor tis-
sue. Here, only performing scDNA-seq experiments can
definitively reveal the clonal structure of a tumor. If
one wishes to correctly link mutation with transcription
profiles, ignoring the clonal structure of a tumor could
be misleading. Several analytical methods that address
this problem have recently emerged: (i) clonealign [91]
assumes a copy number dosage effect on transcription
to assign gene expression states to clones, (ii) cardelino
[342] aligns clone-specific SNVs in scRNA-seq to those
inferred from bulk exome data in order to infer clone-
specific expression patterns, and (iii)MATCHER [18] uses
manifold alignment to combine scM&T-seq [336] with sc-
GEM [337], leveraging the common set of loci. All of these
methods are based on biologically meaningful assump-
tions on how to summarize data measurements across
different measurement types and samples, despite their
different physical origin.
Open problems
Experimental technologies that enable taking multiple
measurement types in the same cell (approach +M1C in
Fig. 6 and Table 4) are on the rise and will allow to assay
more cells at higher fidelity and reduced cost. While this
type of data naturally links measurement types within sin-
gle cells, the SCDS challenge is to account for dependen-
cies among those measurement types for any obtainable
combinations of them. As a prominent example, consider
how gene expression increases with higher genomic copy
number, a phenomenon known as measurement linkage
[343], which has not been addressed for different mea-
surement types taken in the same cell. Statistical models
for leveraging those measurement type combinations thus
pose formidable SCDS challenges.
While progress on the approach +M1C may gradually
render approach +M+C obsolete, +M+C will remain the
easier—or the only feasible—approach for many measure-
ment type combinations for a while. At the same time,
any advances in characterizing dependencies between dif-
ferent measurement types acquired from separate cells
(+M+C) provide further ground work for linking them
when acquired from the same cell (+M1C). Take the exam-
ple from above, where copy number profiles will impact
gene expression measurements. Here, an approach that
accounts for this in +M+C exists (clonealign [91]) and
could be extended to +M1C datasets. For approach +M+C,
the possibility to integrate data from single cells with data
from bulk sequencing of the same cell population also
holds promise, for example, by using bulk genotypes for
imputation of sites with no sequencing coverage in single
cells. Finally, knowing how to link (different) measure-
ment types acquired from different cells is essential for
building reference systems across experiments, such as
cell atlases (see also approaches +X+S and +all, and
“Challenge III: Mapping single cells to a reference atlas”).
Thus, exploring further combinations of measurement
types and their measurement linkage in +M+C datasets
remains as a central SCDS challenge.
No matter which combinations of measurement types
become available—the amounts of material underlying
most measurements will remain tiny, limited by the
amounts within a single cell as well as by a limited num-
ber of cells available from a particular cell population.
This means that one overarching theme will persist: anal-
yses like training models or mapping quantities on one
another will suffer from missing entire views—samples,
time points, or measurement types. Thus, integrating
data across experiments and different measurement types
will further compound the challenge of missing data
that we already discussed for non-integrative approaches
(see “Challenge I: Handling sparsity in single-cell RNA
sequencing” and “Challenge VI: Dealing with errors and
missing data in the identification of variation from single-
cell DNA sequencing data”).
Challenge XI: Validating and benchmarking analysis tools
for single-cell measurements
With the advances in sc-seq and other single-cell tech-
nologies, more and more analysis tools become avail-
able for researchers, and even more are being devel-
oped and will be published in the near future. Thus,
the need for datasets and methods that support sys-
tematic benchmarking and evaluation of these tools is
becoming increasingly pressing. To be useful and reli-
able, algorithms and pipelines should be able to pass
the following quality control tests: (i) They should pro-
duce the expected results (e.g., reconstruct phylogenies,
estimate differential expressions, or cluster the data) of
high quality and outperform existing methods, if such
methods exist. (ii) They should be robust to high lev-
els of sequencing noise and technological biases, includ-
ing PCR bias, allele dropout, and chimeric signals.
In addition, benchmarking should be conducted in a
systematic way, following established recommendations
[344, 345].
Evaluation of tool performance requires benchmark-
ing datasets with known ground truth. Such data should
include cell populations with known genomic composi-
tions and population structures, in other words where fre-
quencies of clones and alleles are known. Currently, such
datasets are scarce—with some notable exceptions [346,
347]—because generating them in genuine laboratory set-
tings is time-, labor-, and cost-intensive. Experimental
benchmark datasets for evolutionary analysis of single-
cell populations are even harder to obtain, as they require
follow-up samples with known information about evolu-
tionary trajectories and developmental times. With lack
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of time-resolved measurements, only anecdotal evidence
exists on, for instance, how the accuracy of phylogenetic
inferences is affected by data quality. Availability of such
gold-standard datasets would benefit single-cell genomics
research enormously.
Due to aforementioned difficulties, the most affordable
sources of benchmarking and validation data are in silico
simulations. Simulations provide ground truth test exam-
ples that can be rapidly and cost-effectively generated
under different assumptions. However, development of
reliable simulation tools requires design and implementa-
tion of models that capture the essence of underlying bio-
logical processes and technological details of single-cell
technologies and high-throughput sequencing platforms,
establishing single-cell data simulation as a methodologi-
cally involved challenge.
Status
Recent studies [104, 111, 148, 157, 348] show that sys-
tematic benchmarking of different single-cell analysis
methodologies has begun. However, to the best of our
knowledge, there is still a shortage of single-cell data simu-
lation tools, for all the possible use cases. Many single-cell
data analysis packages include their own ad hoc data sim-
ulators [111, 211, 241, 264, 349–353]. However, these sim-
ulators are usually not available as separate tools or even
as a source code, tailored to specific problems studied
in corresponding papers and sometimes not comprehen-
sively documented, thus limiting their utility for the broad
research community. Furthermore, since such simulators
are used only as auxiliary subroutines inside particular
projects and are not published as stand-alone tools, they
themselves are usually not guaranteed to be evaluated,
and therefore, the accuracy of their reflection of real
biological and technological processes can remain unclear.
There are few exceptions known to us, including the tools
Splatter [354], powsimR [355], and SymSim [356], which
provide frameworks for simulation of scRNA-seq data
and whose accuracy has been validated by comparison of
its results with real data. For single-cell phylogenomics,
cancer genome evolution simulators are being designed
[357–359].
Open problems
Current simulation tools mostly concentrate on differen-
tial expression analysis, while comprehensive simulation
methods for other important aspects of sc-seq analysis
are still to be developed. In particular, to the best of our
knowledge, no such tool is available for scDNA-seq data.
With single-cell phylogenomics, one would like to
assess the accuracy of methods for phylogenetic inference
and subclone identification, or the power of population
genetics methods for estimating parameters of interest
(e.g., tests for selection and epistatic interactions in cancer,
see “Challenge IX: Inferring population genetic parame-
ters of tumor heterogeneity bymodel integration”). To this
end, realistic and comprehensive (w.r.t. the evolutionary
phenomena) simulation tools are required.
Another interesting computational problem is the
development of tools for validation of simulated sc-seq
datasets themselves by their comparison with real data
using a comprehensive set of biological parameters. The
first such tool for scRNA-seq data is countsimQC [360],
but similar tools for scDNA-seq data are needed. Finally,
most of the simulators concentrate on modeling of bio-
logically meaningful data, while ignoring or simplifying
models for sc-seq errors and artifacts.
Another important challenge in single-cell analysis tool
validation is the selection of comprehensive evaluation
metrics, which should be used for comparison of differ-
ent analysis results with each other and with the ground
truth. For single-cell data, it is particularly complicated,
since many analysis tools deal with heterogeneous clone
populations, which possess multiple biological charac-
teristics to be inferred and analyzed. Development of
a single measure that captures several of these charac-
teristics is complicated, and in many cases impossible.
For example, validation of tools for imputation of cel-
lular and transcriptional heterogeneity should simulta-
neously evaluate two measures: (i) how close are the
reconstructed and true cellular genomic profiles and (ii)
how close are reconstructed and true SNV/haplotype
frequency distributions. Development of synthetic mea-
sures that capture several such characteristics (e.g., based
on utilization of earth mover’s distance [361]) is highly
important.
When simulating datasets in general, the circularity of
simulating and inferring parameters under the same—
possibly simplistic—model should be critically assessed,
as should potential biases. Thus, further evaluation on
empirical datasets for which some ground truth is known
will be invaluable. Ideally, all single-cell analysis fields
should define a standard set of benchmark datasets that
will allow for assessing and comparing methods or come
up with a regular data analysis challenge. This approach
has been very successful, for example, in protein struc-
ture prediction4 and metagenomic analyses5. A first step
in this direction was the recent single-cell transcriptomics
DREAM challenge6.
Finally, drawing on all the exemplary benchmarking
studies mentioned above, it would be immensely ben-
eficial to bring all the required efforts together in a
community-supported benchmarking platform: (i) simu-
lating datasets and validating that they capture important
characteristics of real data, (ii) curating ground truths for
4http://predictioncenter.org/
5https://data.cami-challenge.org
6https://www.synapse.org/#!Synapse:syn15665609/wiki/582909
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real datasets, and (iii) agreeing on comprehensive eval-
uation metrics. Ideally, such a benchmarking framework
would remain dynamic beyond an initial publication—to
allow ongoing comparison of methods as new approaches
are proposed and to easily extend it to entirely new fields
of method development.
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